Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol CAV1 contributors: mct/shn - updated : 16-03-2018
HGNC name caveolin 1, caveolae protein, 22kDa
HGNC id 1527
ASSOCIATED DISORDERS
corresponding disease(s) BSCL3
Other morbid association(s)
TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
tumoral     --over  
in T cell leukemia, lung carcinoma and breast carcinoma cell lines
tumoral   deletion    
or amplified in prostate carcinoma
tumoral     --low  
in ovarian carcinoma
tumoral   amplification    
coamplified with MET oncogene in gastric cancer
tumoral       loss of function
through mutations, in cervical cancer
tumoral     --over  
correlates with longer survival in malignant melanoma metastases, and high in melanoma cells correlates with longer survival in primary malignant melanoma
constitutional       loss of function
decreases basolateral K(+) channel activity and depolarizes the cell membrane potential in the distal convoluted tubule (DCT) at least in part by suppressing the stimulatory effect of SRC on KCNJ10
constitutional   deletion    
impaired the ability of HSCs to differentiate into mature blood cells
constitutional     --low  
in patients with Moyamoya disease and markedly decreased in RNF213 variant carriers
Susceptibility
  • to hypertension and metabolic syndrome
  • to primary open-angle glaucoma
  • subjects from Iceland mapped the first common genetic risk factor for POAG to a small region of the genome on chromosome 7q31 that contains the caveolin genes CAV1 (
  • Variant & Polymorphism SNP , other
  • polymorphisms protecting against hypertension and metabolic syndrome
  • rs4236601[A], associated with primary open-angle glaucoma
  • Candidate gene
    Marker
    Therapy target
  • Treatment of cav1-/- mice with glucose drastically increased survival and reestablished progression of the cell cycle (
  • treatment of Cav1-/- mice with either MnTMPyP (a superoxide scavenger) or l-NAME (a NOS inhibitor) reversed their pulmonary vascular pathology and Pulmonary hypertension phenotype (
  • ANIMAL & CELL MODELS
  • Caveolin-1 null mice display hyperproliferative and vascular abnormalities (
  • mice disrupted for Cav1 display vascular dysfunction and pulmonary defects (
  • Cav-1(-/-) mice displayed a decreased percentage of B cells and an increased percentage of M cells in the bone marrow and peripheral blood, and these changes were due to an increased number of HSCs
  • mice deficient in the Cav1 gene have no caveolae structures in several nonmuscle cell types, a dilated cardiomyopathy in the left ventricular chamber including an enlarged ventricular chamber diameter and a ventricular hypertrophy (
  • genetic depletion of caveolin-1 in fibroblasts abolished the antiproliferative effect of carbon monoxide (
  • caveolin-1 gene-disrupted mice display impaired liver regeneration and low survival after a partial hepatectomy (